Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANA MEREDITH CHASE

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1396888947
CMS profile
290086
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$181,662.00

124 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $81,248.54 44
GlaxoSmithKline, LLC. $28,960.30 12
Genmab U.S., Inc. $25,654.24 15
Seagen Inc. $22,415.88 15
EISAI INC. $12,253.09 16
Merck Sharp & Dohme LLC $8,606.79 7
Myriad Genetic Laboratories, Inc. $1,487.50 3
Clovis Oncology, Inc. $399.42 5
Intuitive Surgical, Inc. $245.27 1
Baxter Healthcare $120.31 1
Becton, Dickinson and Company $104.98 2
Medtronic, Inc. $93.94 1
Regeneron Pharmaceuticals, Inc. $37.96 1
Smith+Nephew, Inc. $33.78 1

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

124 matching records · $181,662.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 124 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 124.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $5,500.0012/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914955185 CMS
Medtronic, Inc. $93.9412/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930699135 CMS
AstraZeneca Pharmaceuticals LP $184.4812/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914725077 CMS
AstraZeneca Pharmaceuticals LP $124.9912/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914921609 CMS
AstraZeneca Pharmaceuticals LP $209.9912/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915523727 CMS
AstraZeneca Pharmaceuticals LP $5,500.0012/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914684157 CMS
GlaxoSmithKline, LLC. $121.9012/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944616051 CMS
GlaxoSmithKline, LLC. $402.2112/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944616055 CMS
Genmab U.S., Inc. $92.9312/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581033 CMS
Genmab U.S., Inc. $7,170.0012/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581029 CMS
Genmab U.S., Inc. $378.2011/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581025 CMS
AstraZeneca Pharmaceuticals LP $5,500.0011/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915715381 CMS
AstraZeneca Pharmaceuticals LP $5,500.0011/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914850987 CMS
AstraZeneca Pharmaceuticals LP $39.9311/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915067919 CMS
AstraZeneca Pharmaceuticals LP $1,400.8511/17/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915510643 CMS
EISAI INC. $1,560.0011/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028293 CMS
EISAI INC. $1,950.0011/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028297 CMS
EISAI INC. $123.1011/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028301 CMS
EISAI INC. $780.0011/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028305 CMS
EISAI INC. $1,560.0011/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028309 CMS
EISAI INC. $60.0011/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028313 CMS
EISAI INC. $780.0011/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026908028317 CMS
Eisai Inc. $631.6611/15/2022 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155796132 CMS
Eisai Inc. $1,050.1411/15/2022 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155796364 CMS
Eisai Inc. $316.9811/15/2022 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155796398 CMS
Eisai Inc. $453.7211/15/2022 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155796650 CMS
Eisai Inc. $538.6011/15/2022 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155796836 CMS
Eisai Inc. $18.3011/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026935311763 CMS
Eisai Inc. $14.3311/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026935311765 CMS
AstraZeneca Pharmaceuticals LP $5,500.0011/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915499453 CMS
AstraZeneca Pharmaceuticals LP $2,050.0011/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915506113 CMS
AstraZeneca Pharmaceuticals LP $104.1711/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915477253 CMS
Genmab U.S., Inc. $109.3111/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581021 CMS
AstraZeneca Pharmaceuticals LP $483.3411/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914667789 CMS
AstraZeneca Pharmaceuticals LP $39.0611/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914682479 CMS
AstraZeneca Pharmaceuticals LP $2,336.4911/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915356691 CMS
AstraZeneca Pharmaceuticals LP $114.4311/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915790147 CMS
Genmab U.S., Inc. $1,185.0011/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581017 CMS
Genmab U.S., Inc. $344.7811/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581013 CMS
GlaxoSmithKline, LLC. $4,000.0010/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944616039 CMS
Genmab U.S., Inc. $7,170.0010/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581009 CMS
AstraZeneca Pharmaceuticals LP $5,500.0010/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915139381 CMS
AstraZeneca Pharmaceuticals LP $5,500.0010/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915581949 CMS
AstraZeneca Pharmaceuticals LP $5,500.0010/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915748245 CMS
Genmab U.S., Inc. $30.0010/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581005 CMS
AstraZeneca Pharmaceuticals LP $4,966.2510/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026915178631 CMS
Genmab U.S., Inc. $545.8910/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921580997 CMS
Genmab U.S., Inc. $319.5810/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026921581001 CMS
AstraZeneca Pharmaceuticals LP $114.9510/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914738437 CMS
AstraZeneca Pharmaceuticals LP $562.9810/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026914909199 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $287,401.65 290
PY2020 $102,429.83 75
PY2021 $100,131.71 70
PY2022 $181,662.00 124
PY2023 $253,425.55 170
PY2024 $219,218.10 141
PY2025 $144,892.79 99

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DANA MEREDITH CHASE, NPI 1396888947. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1396888947.
APA 7
IndustryPayments. (2026). DANA MEREDITH CHASE, NPI 1396888947 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1396888947
Bluebook
DANA MEREDITH CHASE, NPI 1396888947, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1396888947.

Source: Centers for Medicare & Medicaid Services, Open Payments.